Established breast cancer stem cell markers do not correlate with in vivo tumorigenicity of tumor-initiating cells

International Journal of Oncology

Volumn 41, Issue 6, 2012, Pages 1932-1942

  Lehmann, Christian ^a   Jobs, Gabriele ^a   Thomas, Markus ^a   Burtscher, Helmut ^a   Kubbies, Manfred ^a  

^a ROCHE DIAGNOSTICS GMBH   (Germany)

Author keywords

Breast cancer; Mammospheres; Stem cells; Tumor initiating cells

Indexed keywords

ALDEHYDE DEHYDROGENASE; CD24 ANTIGEN; CELL SURFACE MARKER; CYTOKERATIN 18; CYTOKERATIN 5; HERMES ANTIGEN; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX1; TUMOR MARKER; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER STAGING; CANCER STEM CELL; CARCINOGENICITY; CELL CYCLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN ISOLATION; TUMOR GROWTH; TUMOR XENOGRAFT;

AGED; AGED, 80 AND OVER; ANIMALS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPHENOTYPING; MICE; MICE, INBRED NOD; MICE, SCID; MIDDLE AGED; NEOPLASTIC STEM CELLS; SPHEROIDS, CELLULAR; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84869829467     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1654     Document Type: Article

References (40)

1. Wood LD, Parsons DW, Jones S, et al: The genomic landscapes of human breast and colorectal cancers. Science 318: 1108-1113, 2007. (Pubitemid 350134889)
2. Stingl J and Caldas C: Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 7: 791-799, 2007. (Pubitemid 47463670)
3. Vermeulen L, Sprick MR, Kemper K, Stassi G and Medema JP: Cancer stem cells - old concepts, new insights. Cell Death Differ 15: 947-958, 2008. (Pubitemid 351712600)
4. Polyak K and Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273, 2009.
5. Hill RP: Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 66: 1891-1895, 2006.
6. Shipitsin M and Polyak K: The cancer stem cell hypothesis: in search of definitions, markers, and relevance. Lab Invest 88: 459-463, 2008. (Pubitemid 351581449)
7. Cho RW and Clarke MF: Recent advances in cancer stem cells. Curr Opin Genet Dev 18: 48-53, 2008. (Pubitemid 351694448)
8. Polyak K: Breast cancer stem cells: a case of mistaken identity? Stem Cell Rev 3: 107-109, 2007.
9. Lawson JC, Blatch GL and Edkins AL: Cancer stem cells in breast cancer and metastasis. Breast Cancer Res Treat 118: 241-254, 2009.
10. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ and Clarke MF: Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003. (Pubitemid 36418143)
11. Grimshaw MJ, Cooper L, Papazisis K, et al: Mammosphere culture of metastatic breast cancer cells enriches for tumorigenic breast cancer cells. Breast Cancer Res 10: R52, 2008.
12. Shipitsin M, Campbell LL, Argani P, et al: Molecular definition of breast tumor heterogeneity. Cancer Cell 11: 259-273, 2007. (Pubitemid 46349843)
13. Park SY, Gönen M, Kim HJ, Michor F and Polyak K: Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. J Clin Invest 120: 636-644, 2010.
14. Meyer MJ, Fleming JM, Ali MA, Pesesky MW, Ginsburg E and Vonderhaar BK: Dynamic regulation of CD24 and the invasive, CD44pos CD24neg phenotype in breast cancer cell lines. Breast Cancer Res 11: R82, 2009.
15. Reim F, Dombrowski Y, Ritter C, et al: Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells. Cancer Res 69: 8058-8066, 2009.
16. -/low subpopulation and the side population of breast cancer cells. Anticancer Res 29: 2147-2157, 2009.
17. Creighton CJ, Li X, Landis M, et al: Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc Natl Acad Sci USA 106: 13820-13825, 2009.
18. Aulmann S, Waldburger N, Penzel R, Andrulis M, Schirmacher P and Sinn HP: Reduction of CD44(+)/CD24(-) breast cancer cells by conventional cytotoxic chemotherapy. Hum Pathol 41: 574-581, 2010.
19. Ginestier C, Hur MH, Charafe-Jauffret E, et al: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567, 2007. (Pubitemid 350056407)
20. Charafe-Jauffret E, Ginestier C, Iovino F, et al: Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 69: 1302-1313, 2009.
21. Charafe-Jauffret E, Ginestier C, Iovino F, et al: Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 16: 45-55, 2010.
22. Han JS and Crowe DL: Tumor initiating cancer stem cells from human breast cancer cell lines. Int J Oncol 34: 1449-1453, 2009.
23. Ouyang G, Wang Z, Fang X, Liu J and Yang CJ: Molecular signaling of the epithelial to mesenchymal transition in generating and maintaining cancer stem cells. Cell Mol Life Sci 67: 2605-2618, 2010.
24. Vesuna F, Lisok A, Kimble B and Raman V: Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression. Neoplasia 11: 1318-1328, 2009.
25. Mani SA, Guo W, Liao MJ, et al: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715, 2008. (Pubitemid 351636299)
26. Dontu G, Abdallah WM, Foley JM, et al: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270, 2003. (Pubitemid 36583168)
27. Ponti D, Costa A, Zaffaroni N, et al: Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 65: 5506-5511, 2005. (Pubitemid 40911148)
28. Ivascu A and Kubbies M: Diversity of cell-mediated adhesions in breast cancer spheroids. Int J Oncol 31: 1403-1413, 2007.
29. Ivascu A and Kubbies M: Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis. J Biomol Screen 11: 922-932, 2006. (Pubitemid 44847146)
30. Lim E, Vaillant F, Wu D, et al: Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 15: 907-915, 2009.
31. Stuelten C, Mertins SD, Busch IJ, et al: Complex display of putative tumor stem cell markers in the NCI60 tumor cell line panel. Stem Cells 28: 649-660, 2010.
32. Neumeister V, Agarwal S, Bordeaux J, Camp RL and Rimm DL: In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis. Am J Pathol 176: 2131-2138, 2010.
33. Glinsky GV, Berezovska O and Glinskii AB: Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115: 1503-1521, 2005. (Pubitemid 40814659)
34. Bergamaschi A, Kim YH, Kwei KA, et al: CAMK1D amplification implicated in epithelial-mesenchymal transition in basal-like breast cancer. Mol Oncol 2: 327-239, 2008.
35. Kotaja N and Sassone-Corsi P: Plzf pushes stem cells. Nat Genet 36: 551-553, 2004. (Pubitemid 38715977)
36. DeAngelis JT, Li Y, Mitchell N, Wilson L, Kim H and Tollefsbol TO: 2D difference gel electrophoresis analysis of different time points during the course of neoplastic transformation of human mammary epithelial cells. J Proteom Res 10: 447-458, 2011.
37. Martin JC, Herbert BS and Hocevar BA: Disabled-2 downregulation promotes epithelial-to-mesenchymal transition. Br J Cancer 103: 1716-1723, 2010.
38. Sathyanarayana UG, Padar A, Huang CX, et al: Abberant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma. Clin Cancer Res 9: 6389-6394, 2003. (Pubitemid 38031824)
39. Ponti D, Zaffaroni N, Capelli C and Diadone MG: Breast cancer stem cells: an overview. Eur J Cancer 42: 1219-1224, 2006. (Pubitemid 43795092)
40. Hu M and Polyak K: Microenvironmental regulation of cancer development. Curr Opin Genet Dev 18: 27-34, 2008. (Pubitemid 351694443)